Single-cell proteomics has advanced significantly, enabling the analysis of thousands of proteins within individual cells. This progress is driven by improvements in experimental design, sample preparation, separation techniques, mass spectrometry instrumentation, and data analysis. Label-free and multiplexed methods are both being actively developed, each offering unique advantages. Label-free techniques rely on direct quantification of proteins based on peptide mass spectral intensities, while multiplexed approaches use isobaric labels like TMT for high-throughput analysis. Recent advancements include the development of hyperSCP, which combines TMT and SILAC labeling for up to 28-plex analysis, and plexDIA, which improves throughput and data completeness. Innovations in sample preparation, such as the Tecan Uno Single Cell Dispenser, have simplified workflows and improved accessibility. Ultra-low-flow nanoLC and microfabricated pillar array columns have enhanced sensitivity and resolution. Mass spectrometry platforms like timsTOF and Orbitrap Astral offer improved resolution and throughput. Data analysis tools are evolving to handle the complexity of single-cell datasets, with approaches like DIA and AI-based methods improving proteome coverage. Spatial proteomics, using techniques like laser capture microdissection and deep ultraviolet laser ablation, is expanding the understanding of protein distribution within tissues. Post-translational modifications are being quantified at the single-cell level, with emerging applications in cancer research and biomarker discovery. Despite challenges in depth of proteome coverage and throughput, single-cell proteomics holds great potential for personalized medicine and therapeutic advancements.Single-cell proteomics has advanced significantly, enabling the analysis of thousands of proteins within individual cells. This progress is driven by improvements in experimental design, sample preparation, separation techniques, mass spectrometry instrumentation, and data analysis. Label-free and multiplexed methods are both being actively developed, each offering unique advantages. Label-free techniques rely on direct quantification of proteins based on peptide mass spectral intensities, while multiplexed approaches use isobaric labels like TMT for high-throughput analysis. Recent advancements include the development of hyperSCP, which combines TMT and SILAC labeling for up to 28-plex analysis, and plexDIA, which improves throughput and data completeness. Innovations in sample preparation, such as the Tecan Uno Single Cell Dispenser, have simplified workflows and improved accessibility. Ultra-low-flow nanoLC and microfabricated pillar array columns have enhanced sensitivity and resolution. Mass spectrometry platforms like timsTOF and Orbitrap Astral offer improved resolution and throughput. Data analysis tools are evolving to handle the complexity of single-cell datasets, with approaches like DIA and AI-based methods improving proteome coverage. Spatial proteomics, using techniques like laser capture microdissection and deep ultraviolet laser ablation, is expanding the understanding of protein distribution within tissues. Post-translational modifications are being quantified at the single-cell level, with emerging applications in cancer research and biomarker discovery. Despite challenges in depth of proteome coverage and throughput, single-cell proteomics holds great potential for personalized medicine and therapeutic advancements.